Sort by
Keyphrases
Angiogenic
100%
Selective Binding
100%
Vascular Endothelial Growth Factor 165
100%
Sulfated Hyaluronic Acid
100%
VEGF165
83%
Binding Properties
50%
Hyaluronic Acid
33%
Repeating Unit
33%
Sulfation
33%
Natural Polymers
16%
Nanoparticles
16%
Biomaterials
16%
Therapeutic Benefits
16%
Aptamer
16%
Hydroxyl
16%
Sequestration
16%
Human Umbilical Vein Endothelial Cells (HUVECs)
16%
Angiogenesis
16%
Stronger Binding
16%
Biopolymers
16%
Non-selective
16%
Antiangiogenic Activity
16%
Human Dermal Microvascular Endothelial Cells (HDMECs)
16%
Sulfate Group
16%
Simple Synthesis
16%
Endothelial Cell Proliferation
16%
Extracellular Proteins
16%
N-acetylglucosamine
16%
Antiangiogenic
16%
Pathological Angiogenesis
16%
Endothelial Viability
16%
Semi-synthetic
16%
Angiogenesis-dependent Diseases
16%
Dissociation Rate Constant
16%
Drug Delivery Applications
16%
Antiangiogenic Therapy
16%
Equilibrium Binding Constant
16%
Cost-effective Synthesis
16%
Anti-VEGF Antibody
16%
Endothelial Tube Formation
16%
Association Rate Constant
16%
Retinitis pigmentosa
16%
Fast Association
16%
Wet Age-related Macular Degeneration
16%
Slow Dissociation
16%
Strong Equilibrium
16%
Avastin
16%
Immunology and Microbiology
Vasculotropin 165
100%
Angiogenesis
50%
Sulfation
50%
Binding Affinity
25%
Cell Proliferation
25%
Cell Survival
25%
Dermal Microvascular Endothelial Cell
25%
Umbilical Vein Endothelial Cell
25%
Bevacizumab
25%
Antiangiogenic Activity
25%
Dissociation Rate Constant
25%
Vasculotropin Antibody
25%
Association Rate Constant
25%
Immunology
25%
Pharmacology, Toxicology and Pharmaceutical Science
Hyaluronic Acid
100%
Vasculotropin 165
100%
Disease
37%
Antiangiogenic
25%
Nanoparticle
12%
Malignant Neoplasm
12%
Age Related Macular Degeneration
12%
Biopolymer
12%
Aptamer
12%
N Acetylglucosamine
12%
Bevacizumab
12%
Vasculotropin Antibody
12%
Retinitis pigmentosa
12%
Biomaterial
12%
Sulfate
12%